Narcolepsy
📧 Sign up to get email alerts when something new happens for Narcolepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy [Phase 1]
Phase 1 trial evaluating TAK-925 in healthy volunteers and narcolepsy patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy [Phase 1]
Phase 1 trial update for TAK-925 in healthy volunteers and narcolepsy patients; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients [Phase 2]
Phase 2 trial evaluating THN102 for safety and efficacy in reducing sleepiness in narcolepsy patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" [Phase 3]
Phase 3 clinical trial update for JZP-110 evaluating safety and efficacy in excessive daytime sleepiness associated with narcolepsy complete…
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" [Phase 3]
Phase 3 long-term safety study of JZP-110 in narcolepsy and obstructive sleep apnea has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: The Effect of Caffeine on the Narcoleptic Patients [Phase 1, Phase 2]
Clinical trial update on caffeine effects in narcolepsy patients, spanning Phase 1 and Phase 2, completed.
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Body Weight Regulation in Patients With Narcolepsy
This update reports on a completed study examining body weight regulation in patients with narcolepsy.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Sleep Disorders of Patients With Diseases of the Nervous System
This clinical trial update notes the completion of a National Institute of Neurological Disorders and Stroke study investigating sleep disor…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy [Phase 2]
Phase 2 clinical trial evaluating GSK189254 for narcolepsy has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy. [Phase 3]
Phase 3 trial evaluating BF2.649 for excessive daytime sleepiness in narcolepsy has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant) [Phase 3]
A Phase 3 long-term open-label study of pitolisant (BF2.649) for narcolepsy with cataplexy has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Cardiovascular Variability and Heart Rate Arousal Response in Idiopathic Hypersomnia
This clinical trial update notes the completion of a study evaluating cardiovascular variability and heart rate arousal response in idiopath…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
A completed observational study evaluating risks of side effects, drug abuse, and dependence in patients prescribed Xyrem (sodium oxybate) f…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV) [Phase 3]
Phase 3 trial update on pitolisant (BF2.649) as add-on to sodium oxybate for narcolepsy.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics [Phase 1]
Phase 1, single-dose study of JZP-386 to evaluate safety, pharmacokinetics and pharmacodynamics has completed, sponsored by Concert Pharmace…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy [Phase 2]
Phase 2 trial evaluating safety and effectiveness of ADX-N05 for excessive daytime sleepiness in narcolepsy has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Clarithromycin for the Treatment of Hypersomnia [Phase 2]
A Phase 2 trial evaluating clarithromycin for hypersomnia disorders (hypersomnia, idiopathic hypersomnia, and narcolepsy) has completed with…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy [Phase 2]
A Phase 2 safety and effectiveness study of a single dose of JNJ-17216498 in patients with narcolepsy has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy [Phase 2]
Pfizer conducted a Phase 2 trial of a novel compound for excessive daytime sleepiness in narcolepsy; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome [Phase 3]
Phase 3 clinical trial update for PROVIGIL (modafinil) in children and adolescents with excessive sleepiness due to narcolepsy or obstructiv…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy [Phase 3]
Phase 3 trial of Xyrem (sodium oxybate) for narcolepsy has been completed. Results were posted on November 25, 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies [NA]
This trial evaluated a method for assessing driving ability in patients with wakefulness pathologies such as narcolepsy and hypersomnia. The…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy [Phase 3]
Phase 3 study evaluating BF2.649 with add-on Modafinil for cataplexy in narcolepsy has completed, reporting efficacy and safety findings.
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy [Phase 3]
A Phase 3 study evaluating modafinil (Provigil) for excessive sleepiness in children and adolescents with narcolepsy has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy [Phase 3]
Phase 3 trial evaluating BF2.649 for excessive daytime sleepiness in narcolepsy has completed, assessing efficacy and safety.